Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-19-276938
Filing Date
2019-10-29
Accepted
2019-10-29 08:11:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 11 TO SCHEDULE 14D-9 d806266dsc14d9a.htm SC 14D9/A 16345
  Complete submission text file 0001193125-19-276938.txt   17996
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filed by) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Subject) CIK: 0001609351 (see all company filings)

EIN.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-88577 | Film No.: 191174503
SIC: 2836 Biological Products, (No Diagnostic Substances)